News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
85,736 Results
Type
Article (2674)
Company Profile (58)
Press Release (83003)
Section
Business (32636)
Career Advice (69)
Deals (6089)
Drug Delivery (7)
Drug Development (9199)
Employer Resources (9)
FDA (1597)
Job Trends (2256)
News (47651)
Policy (2756)
Tag
Academia (181)
Accelerated approval (1)
Allergies (21)
Alliances (3250)
ALS (10)
Alzheimer's disease (171)
Antibody-drug conjugate (ADC) (14)
Approvals (1649)
Artificial intelligence (21)
Autoimmune disease (7)
Automation (2)
Bankruptcy (24)
Best Places to Work (2017)
BIOSECURE Act (2)
Biosimilars (7)
Biotechnology (35)
Bladder cancer (15)
Brain cancer (2)
Breast cancer (66)
Cancer (439)
Cardiovascular disease (37)
Career advice (63)
CAR-T (12)
CDC (3)
Cell therapy (47)
Cervical cancer (9)
Clinical research (8137)
Collaboration (66)
Company closure (1)
Compensation (60)
Complete response letters (1)
COVID-19 (280)
CRISPR (4)
C-suite (20)
Cystic fibrosis (8)
Data (573)
Depression (7)
Diabetes (33)
Diagnostics (875)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (7)
Drug pricing (6)
Drug shortages (4)
Duchenne muscular dystrophy (12)
Earnings (28166)
Editorial (3)
Employer branding (2)
Employer resources (9)
Events (9801)
Executive appointments (27)
FDA (2018)
Frontotemporal dementia (4)
Funding (94)
Gene editing (10)
Generative AI (3)
Gene therapy (28)
GLP-1 (97)
Government (336)
Grass and pollen (1)
Guidances (241)
Healthcare (2497)
HIV (11)
IgA nephropathy (6)
Immunology and inflammation (20)
Immuno-oncology (2)
Indications (10)
Infectious disease (294)
Inflammatory bowel disease (10)
Influenza (8)
Intellectual property (7)
Interviews (6)
IPO (4505)
IRA (2)
Job creations (322)
Job search strategy (57)
Kidney cancer (4)
Labor market (7)
Layoffs (50)
Legal (467)
Liver cancer (9)
Lung cancer (88)
Lymphoma (40)
Machine learning (1)
Management (3)
Manufacturing (50)
MASH (12)
Medical device (1836)
Medtech (1838)
Mergers & acquisitions (1741)
Metabolic disorders (97)
Multiple sclerosis (32)
NASH (2)
Neurodegenerative disease (12)
Neuropsychiatric disorders (6)
Neuroscience (268)
NextGen: Class of 2025 (645)
Non-profit (364)
Now hiring (1)
Obesity (54)
Opinion (8)
Ovarian cancer (18)
Pain (10)
Pancreatic cancer (15)
Parkinson's disease (18)
Partnered (1)
Patents (13)
Patient recruitment (10)
Peanut (13)
People (2548)
Pharmaceutical (11)
Pharmacy benefit managers (3)
Phase I (1926)
Phase II (3252)
Phase III (3546)
Pipeline (980)
Policy (13)
Postmarket research (384)
Preclinical (632)
Press Release (5)
Prostate cancer (8)
Radiopharmaceuticals (37)
Rare diseases (38)
Real estate (404)
Recruiting (2)
Regulatory (2266)
Reports (12)
Research institute (187)
Resumes & cover letters (6)
Rett syndrome (1)
RSV (6)
Schizophrenia (14)
Series A (9)
Series B (8)
Service/supplier (5)
Sickle cell disease (4)
Special edition (4)
Spinal muscular atrophy (18)
Sponsored (4)
Startups (210)
Stomach cancer (1)
Supply chain (12)
Tariffs (22)
The Weekly (3)
Vaccines (83)
Venture capital (7)
Weight loss (33)
Women's health (4)
Worklife (3)
Date
Today (7)
Last 7 days (45)
Last 30 days (242)
Last 365 days (4780)
2025 (3389)
2024 (5410)
2023 (6159)
2022 (9174)
2021 (10100)
2020 (9093)
2019 (5594)
2018 (4305)
2017 (3798)
2016 (3061)
2015 (4201)
2014 (2862)
2013 (2039)
2012 (1976)
2011 (2236)
2010 (1890)
Location
Africa (54)
Alabama (5)
Alaska (1)
Arizona (20)
Asia (4213)
Australia (449)
California (1238)
Canada (468)
China (90)
Colorado (82)
Connecticut (51)
Delaware (47)
Europe (11649)
Florida (197)
Georgia (47)
Idaho (3)
Illinois (77)
India (3)
Indiana (69)
Japan (39)
Kansas (21)
Kentucky (2)
Louisiana (6)
Maine (17)
Maryland (175)
Massachusetts (933)
Michigan (38)
Minnesota (79)
Missouri (19)
Montana (5)
Nevada (10)
New Hampshire (10)
New Jersey (446)
New Mexico (2)
New York (370)
North Carolina (155)
North Dakota (2)
Northern California (647)
Ohio (34)
Oregon (2)
Pennsylvania (266)
Rhode Island (6)
South America (168)
Southern California (463)
Tennessee (13)
Texas (168)
United States (4663)
Utah (32)
Virginia (18)
Washington D.C. (7)
Washington State (93)
Wisconsin (12)
85,736 Results for "55".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AB Science announces the successful completion of a 2.55 million euros private placement
August 4, 2025
·
11 min read
Press Releases
MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
September 4, 2025
·
6 min read
Press Releases
CAR T-Cell Therapy Market Size Worth USD 128.55 Billion by 2034
July 22, 2025
·
1 min read
Press Releases
Regenerative Medicine Market Size to Hit USD 169.55 Billion by 2034
June 11, 2025
·
1 min read
Press Releases
Mallia sets strategic course for future and completes €5.5 million financing
June 5, 2025
·
1 min read
Press Releases
Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt
June 17, 2025
·
2 min read
Layoffs
Spruce Axes 55% of Staff, Leaving Shoestring Crew To Focus on New Rare Disease Asset
Spruce Biosciences is cutting over half of its employees as it looks to secure accelerated approval of a Sanfilippo syndrome therapy it recently acquired from BioMarin.
April 28, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Calidi Biotherapeutics Presents systemic oncolytic platform with CD55-Enhanced expression and IL-15 Superagonist Payload at ASCO Annual Meeting
June 2, 2025
·
5 min read
Manufacturing
J&J Adds $2B to US Manufacturing Commitment Amid Trump’s Protracted Tariff Threats
President Donald Trump first threatened pharma tariffs in February and recently said they were imminent. Johnson & Johnson’s new investment adds to a $55 billion pledge made by the company in March.
August 21, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
Optinose Announces $55 Million Registered Direct Offering
Optinose announced that it has entered into agreements for the sale of approximately $55 million of its common stock and pre-funded common stock warrants to a group of existing and new institutional investors in a registered direct offering.
May 9, 2024
·
8 min read
1 of 8,574
Next
